Clough Capital Partners’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-59,076
Closed -$1.21M 129
2019
Q3
$1.21M Sell
59,076
-1,200
-2% -$27.5K 0.1% 73
2019
Q2
$1.57M Buy
60,276
+8,700
+17% +$244K 0.15% 78
2019
Q1
$2M Sell
51,576
-900
-2% -$36.5K 0.18% 81
2018
Q4
$2.21M Sell
52,476
-15,827
-23% -$704K 0.26% 81
2018
Q3
$3.42M Sell
68,303
-61,800
-48% -$2.79M 0.32% 69
2018
Q2
$4.98M Buy
130,103
+12,300
+10% +$529K 0.44% 62
2018
Q1
$4.72M Sell
117,803
-41,600
-26% -$1.75M 0.45% 63
2017
Q4
$5.59M Sell
159,403
-49,300
-24% -$1.44M 0.47% 61
2017
Q3
$4.54M Buy
208,703
+15,800
+8% +$318K 0.3% 74
2017
Q2
$3.59M Sell
192,903
-215,103
-53% -$4.64M 0.25% 77
2017
Q1
$10.9M Buy
408,006
+196,903
+93% +$5.5M 0.69% 47
2016
Q4
$5.52M Sell
211,103
-35,800
-14% -$1.16M 0.37% 74
2016
Q3
$8.02M Sell
246,903
-16,047
-6% -$379K 0.42% 80
2016
Q2
$5.44M Sell
262,950
-110,200
-30% -$1.72M 0.29% 102
2016
Q1
$5.13M Sell
373,150
-19,800
-5% -$277K 0.24% 106
2015
Q4
$6.21M Buy
+392,950
New +$6.16M 0.29% 100

Other funds holding WVE

Clough Capital Partners's WVE Position: Q4 2019 in Review

Clough Capital Partners sold out of Wave Life Sciences (WVE) in Q4 2019, closing a stake of 59,076 shares — an estimated $1.21M sold.

Clough Capital Partners first reported a position in WVE in Q4 2015 and held it in 16 quarters. The position peaked at $10.9M in Q1 2017. 90 funds tracked by Wall St. Rank hold WVE as of Q4 2019.

  • Clough Capital Partners reported no remaining Wave Life Sciences position as of Q4 2019 after selling out during the quarter.
  • Clough Capital Partners sold 59,076 Wave Life Sciences shares in Q4 2019, an estimated $1.21M.
  • Clough Capital Partners first reported a position in Wave Life Sciences in Q4 2015 and held it in 16 quarters.
  • Clough Capital Partners's Wave Life Sciences position peaked at $10.9M in Q1 2017.
  • 90 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2019.

Based on Clough Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.